<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04089540</url>
  </required_header>
  <id_info>
    <org_study_id>NOONA</org_study_id>
    <nct_id>NCT04089540</nct_id>
  </id_info>
  <brief_title>New Intubation Method to Achieve Circulatory Stability and to Reduce Number of Intubation Attempts in Neonates</brief_title>
  <acronym>NOONA</acronym>
  <official_title>New Intubation Method to Achieve Circulatory Stability and to Reduce Number of Intubation Attempts in Neonates. A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Graz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Graz</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized controlled pilot study investigating a new intubation method in newborn
      infants. In contrast to the conventional intubation method, in the new method the respirator
      is connected to the tube prior to insertion into the mouth (oral intubation) or into the nose
      (nasopharyngeal intubation). As a result, an oxygen flow is already administered via the tube
      during the intubation process. Heart rate, arterial oxygen saturation (SpO2) and cerebral
      tissue oxygenation (using near-infrared spectroscopy) are recorded in both the study and
      control groups during intubation.

      Hypothesis

        -  The new intubation method is safe

        -  The new intubation method leads to a reduction in the number of intubation attempts

        -  The new intubation method leads to a reduction of desaturations and bradycardia during
           intubation

        -  In the long term, it could lead to a reduction in morbidity and mortality
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 2016</start_date>
  <completion_date type="Anticipated">May 2020</completion_date>
  <primary_completion_date type="Anticipated">May 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of intubation attempts</measure>
    <time_frame>During intubation process</time_frame>
    <description>Changes in the number of intubation attempts</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of intubation process in minutes</measure>
    <time_frame>During intubation process</time_frame>
    <description>Changes in duration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of desaturations</measure>
    <time_frame>During intubation process</time_frame>
    <description>The number of desaturations below 80% SpO2
The number of bradycardia below 100 beats per minute (bpm), as well as the total amount of time a patient spends less than 100 bpm.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total amount of time of desaturations</measure>
    <time_frame>During intubation process</time_frame>
    <description>The total amount of time in seconds a patient spends below 80% SpO2.
The number of bradycardia below 100 beats per minute (bpm), as well as the total amount of time a patient spends less than 100 bpm.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cerebral tissue oxygenation</measure>
    <time_frame>5 minutes before intubation start till 10 minutes after successful intubation</time_frame>
    <description>Using near-infrared spectroscopy to monitor changes of the cerebral tissue oxygenation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Morbidity</measure>
    <time_frame>up to 2 years</time_frame>
    <description>Changes in morbidity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>up to 2 years</time_frame>
    <description>Changes in mortality</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Intubation; Difficult or Failed</condition>
  <condition>Preterm Infant</condition>
  <condition>Term Infant</condition>
  <arm_group>
    <arm_group_label>Study group: New intubation method</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In the new intubation method the respirator is connected to the tube prior to insertion into the mouth (oral intubation) or into the nose (nasopharyngeal intubation). Therefore an oxygen flow is already administered via the tube during the intubation process.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group: Conventional intubation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>In the control group the respirator is connected to the tube and ventilation is started after the insertion of the tube into the trachea. Therefore there is no oxygen flow administered during the intubation process.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>New intubation method</intervention_name>
    <arm_group_label>Study group: New intubation method</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Conventional intubation method</intervention_name>
    <arm_group_label>Control group: Conventional intubation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Preterm and term born neonates who are hospitalized at neonatal intensive care unit,
             Medical University of Graz, Austria.

          -  Fulfillment of indication for intubation

        Exclusion Criteria:

        - Malformation of the upper respiratory tract
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>4 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nicholas Morris, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Division of Neonatology, Department of Pediatrics and Adolescent Medicine, Medical University of Graz, Austria</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nicholas Morris, MD</last_name>
    <phone>0043 316 385 81126</phone>
    <email>nicholas.morris@medunigraz.at</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marlies Bruckner, MD</last_name>
    <phone>0043 316 385 30752</phone>
    <email>marlies.bruckner@medunigraz.at</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Division of Neonatology, Department of Pediatrics and Adolescent Medicine, Medical University of Graz</name>
      <address>
        <city>Graz</city>
        <zip>8036</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicholas Morris, MD</last_name>
      <phone>+43 316 385 81126</phone>
      <email>nicholas.morris@medunigraz.at</email>
    </contact>
    <investigator>
      <last_name>Nicholas Morris, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Berndt Urlesberger, Professor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gerhard Pichler, Assoz. Prof.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marlies Bruckner, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>September 5, 2019</study_first_submitted>
  <study_first_submitted_qc>September 12, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 13, 2019</study_first_posted>
  <last_update_submitted>September 12, 2019</last_update_submitted>
  <last_update_submitted_qc>September 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 13, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

